Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue | Frank Vinluan | 09/09/20 | National |
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire | Sarah de Crescenzo | 07/21/20 | San Francisco |
Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio | Sarah de Crescenzo | 11/15/19 | San Diego |
Grokker Receives $15,500,000 Series B Round | VentureDeal | 12/01/16 | San Francisco |
Revision Optics Garners $32,000,000 New Round | VentureDeal | 11/11/16 | San Diego |
Denver Health IT Firm Welltok Picks Up $33.7M to Push Wellness Tools | David Holley | 10/05/16 | Boulder/Denver |
Totango Obtains $8,000,000 Series C Financing Round | VentureDeal | 09/15/16 | San Francisco |
C3 IoT Receives $70,000,000 Series D Financing Round | VentureDeal | 09/03/16 | San Francisco |
Eyeing Further Growth, Social Marketer Spredfast Nabs Another $50M | Angela Shah | 06/01/16 | Texas |
Spredfast Garners $50,000,000 New Funding Round | VentureDeal | 06/01/16 | Texas |
The RealReal Receives $40,000,000 Series E Round | VentureDeal | 04/21/16 | San Francisco |
Tizona Therapeutics Obtains $43,000,000 Series B Funding | VentureDeal | 03/08/16 | San Francisco |
Aria Systems Garners $50,000,000 Series E Round | VentureDeal | 02/18/16 | San Francisco |
Stellar Loyalty Obtains $4,000,000 Series A Funding | VentureDeal | 02/09/16 | San Francisco |
Welltok Bolsters Growth With $45M Funding, Silverlink Acquisition | David Holley | 12/03/15 | Boulder/Denver |
Avedro Secures $32,000,000 New Financing Round | VentureDeal | 11/16/15 | Boston |
Crossing Sand Hill: A Q&A With Biotech Venture Vet Nina Kjellson | Alex Lash | 09/30/15 | San Francisco |
Content Marketing Software Dev NewsCred Gets $42M, Plans Hiring Surge | João-Pierre S. Ruth | 09/02/15 | New York |
NewsCred Lands $42,000,000 New Financing Round | VentureDeal | 09/02/15 | New York |
Mobee Obtains $5,000,000 Series A Round | VentureDeal | 08/26/15 | Boston |
Gynesonics Receives $43,000,000 New Round | VentureDeal | 07/22/15 | San Francisco |
Lycera’s End Game? $104M Celgene Deal Could Lead to Buyout | Sarah Schmid Stevenson | 06/11/15 | Detroit Ann Arbor |
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More | Ben Fidler | 04/24/15 | Boston |
Cidara’s $42M Series B May Bring Fungal Therapy to Patients | David Holley | 02/11/15 | San Diego |
Welltok Raises Additional $12M, Readies for Debut With IBM’s Watson | Michael Davidson | 01/08/15 | Boulder/Denver |
In Short Order, Indi Convinces Insurers To Cover Its Lung Test | Alex Lash | 11/05/14 | Seattle |
Texas Roundup: New funds for Castle, Quarri, Omni Water, & Pivot3 | Angela Shah | 08/14/14 | Texas |
With $32M, Boston Anti-Fungal Startup Morphs Into San Diego’s Cidara | Bruce V. Bigelow | 06/30/14 | San Diego |
San Diego Biotech Raises Over $30M to Fight Deadly Fungal Infections | Bruce V. Bigelow | 06/25/14 | San Diego |
Labrys Turns Stalled Pfizer Program into $200M+ Teva Buyout | Ben Fidler | 06/03/14 | San Francisco |